Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

Improving Medication Safety for Kidney Disease with a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice.

Study ID: NCT06820372
Start Date: 2025-06-01
End Date: 2026-05-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

125

Intervention / Treatment

Electronic Drug Dosing and Decision Support Kidney (eDoseCKD) Tool

Sponsor

Nova Scotia Health Authority

Source: clinicaltrials.gov

Share:
Add to list

Caffeinated Chewing Gum on Special Forces Performance

Study ID: NCT06638372
Start Date: 2025-07-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

caffeine

Sponsor

National Taiwan Sport University

Source: clinicaltrials.gov

Share:
Add to list

Outpatient Epcoritamab As 2L in NTE R/R DLBCL

Study ID: NCT06811272
Start Date: 2025-07-16
End Date: 2028-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Epcoritamab

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

CD30biAb-AATC for CD30+ Malignancies

Study ID: NCT05544968
Start Date: 2025-06
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

42

Intervention / Treatment

anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Study ID: NCT06024772
Start Date: 2025-07
End Date: 2027-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

ultiparametric Magnetic Resonance Imaging

Perflutren lipid microsphere

Transrectal Ultrasound

Biopsy of Prostate

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

The REmission of Diabetes Using a PlAnt-based Weight Loss InteRvention (REPAIR) Trial

Study ID: NCT06906172
Start Date: 2025-09
End Date: 2029-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Plant-based intensive lifestyle intervention

Standard of Care

Sponsor

University of Toronto

Source: clinicaltrials.gov

Share:
Add to list

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

Study ID: NCT06748872
Start Date: 2025-07-01
End Date: 2042-08-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

55

Intervention / Treatment

Lymphodepletion

TCR-T cells (MDG1015)

Sponsor

Medigene AG

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Tuberosity Micro Connective Tissue Graft for Treatment of Multiple Adjacent Gingival Recession Defects

Study ID: NCT06650072
Start Date: 2025-09-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

modified coronally advanced tunnel technique combined with multiple palatal micro connective tissue grafts

modified coronally advanced tunnel technique combined with multiple tuberosity micro connective tissue grafts

Sponsor

Gothenburg University

Source: clinicaltrials.gov

Share:
Add to list

An Intervention on Psychosocial Health in Women With Unsuccessful IVF Experience

Study ID: NCT06426472
Start Date: 2025-05-30
End Date: 2026-08-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Web-based support program

Sponsor

Istanbul University - Cerrahpasa

Source: clinicaltrials.gov

Share:
Add to list

Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

Study ID: NCT06608472
Start Date: 2026-11-30
End Date: 2029-10-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

292

Intervention / Treatment

N 0877

Benicar HCT ® Tablets 40 mg/25 mg

Sponsor

Eurofarma Laboratories S.A.

Source: clinicaltrials.gov

Share:
Add to list